This book includes a plain text version that is designed for high accessibility. To use this version please follow this link.
11-02/03 :: February / March 2011


nanotimes


Companies Facts


Furthermore, National Semiconductor introduced the industry’s first full-bridge pulse width modulati- on (PWM) controllers to integrate all four primary- side bridge MOSFET gate drivers. The LM5045 and LM5046 are well-suited for delivering higher effici- ency and higher power density in quarter-brick and eighth-brick power modules used in a variety of high input voltage communications infrastructure applica- tions.


Members of National’s PowerWise® energy-efficient


product family, the LM5045 and LM5046 PWM controllers ease the design of full-bridge topology- based power converters into small form factor power supplies by reducing the number of external power components needed with existing full-bridge solu- tions.


The Company reported sales of $343.9 million and net income of $59.4 million, or 24 cents per dilut- ed share, for the third quarter of fiscal 2011, which ended Feb. 27, 2011. National’s third quarter sales were 12 percent lower than the $390.4 million in sales reported in the second quarter of fiscal 2011 due to inventory adjustments in the distribution channel and seasonally lower shipments to wireless handset customers following the holiday sales period.


Sales in the third quarter of fiscal 2011 were 5% lower than the $361.9 million reported in the third quarter of fiscal 2010. Third quarter net income of $59.4 million, or 24 cents per diluted share, was a decrease from the $83.5 million, or 34 cents per diluted share, in the second quarter of fiscal 2011. One year ago, National reported net income of $53.2 million, or 22 cents per diluted share for the third quarter of fiscal 2010.


http://bit.ly/LM5045video http://www.national.com/


O


xford Medical Diagnostics (OMD), the UK developer of breath based, medical diagnostic


technology for the rapid, non-invasive, accurate and low-cost diagnosis and monitoring of metabo- lic and infectious diseases; and V&F Analyse- und Messtechnik GmbH (V&F), a provider of analytical instruments to a wide range of industries, announced a strategic alliance focusing on the area of mass spectrometry. http://www.vandf.com


http://www.omdiagnostics.com O


xford Nanopore Technologies Ltd. and Accelrys, Inc. (NASDAQ:ACCL) announced the signing


of a partnership agreement. Under the terms of the partnership, Accelrys and Oxford Nanopore will de- velop software to enable complex, real-time analyses of experimental data produced by the Oxford Nano- pore single molecule analysis system. Nanopore-


41


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95